Familial hypercholesterolemia in children and adolescents
Video navigation menu
- Why should FH be detected as early as possible? 00:17
- Results from European studies on homozygous and heterozygous FH 02:18
- Detection of FH in the Netherlands and abroad 05:57
- What are the effects of early detection? 07:02
In children with FH, treatment with statin at 2 years follow-up showed:
- A. regression of IMT (intima-media thickness)
- B. that statin therapy is not sufficient to stabilize IMT
- C. minimally increased IMT
- D. the same pattern for IMT change as in non-affected siblings
The aim of this video is to highlight various aspects that are important for the diagnosis and treatment of Familial Hypercholesterolemia (FH) and thus raise awareness about FH.
Bert Wiegman, MD, PhD is pediatrician and pediatric cardiologist at the Amsterdam UMC, location AMC, The Netherlands. He is involved with the care of children with FH and other dyslipidemias.
The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
This educational program was sponsored by unrestricted educational grants from Amgen and Novartis.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: